News • Smart pill
Swallowed sensor sends signal if you’re sick
Researcher have created an ingestible sensor to non-invasively monitor indicators of disease in the stomach and intestines.
Therapy
News • high-intensity focused ultrasound
Prostate cancer ultrasound treatment effective as others
Using high energy ultrasound beams to destroy prostate cancer tumours may be as effective as surgery or radiotherapy, but with fewer side effects. A new study, carried out at six hospitals across the UK, tracked 625 men with prostate cancer who received a type of treatment called high-intensity focused ultrasound (HIFU).
News • Epidemics
Animal health drug could stop outbreaks of malaria and Zika virus
Medicines given to household pets to kill fleas and ticks might be effective for preventing outbreaks of malaria, Zika fever and other dangerous insect-borne diseases that infect millions of people worldwide, according to a new study led by scientists at Calibr, a non-profit drug discovery institute closely affiliated with Scripps Research and TropIQ Health Sciences, a Dutch social enterprise.
News • Plaster
Self-adhesive drug-eluting patch to treat oralulcers
Until now ulcers inside the mouth have been treated using creams or mouthwashes for the whole mouth. A new biodegradable patch administers steroids directly to oral ulcers and forms a protective barrier. Scientists from the University of Sheffield’s School of Clinical Dentistry, working in close collaboration with Dermtreat A/S from Copenhagen, have developed a unique patch using special…
News • Hand in hand
Why being left-handed matters for mental health treatment
Being left-handed apparently means a lot more than gripping things differently than most, researchers find. This sheds a new light on mental health treatment, because current therapies for the most common mental health problems could be ineffective or even detrimental to about 50 percent of the population. For more than 40 years, hundreds of studies suggest that each hemisphere of the brain is…
News • Therapy
A 'super' receptor that helps kill HIV infected cells
While treatments for HIV mean that the disease is no longer largely fatal, the world still lacks a true therapy that can eradicate the virus across a globally—and genetically different—population.
News • Oncology
Breaking through a tumor's defenses
Babraham Institute researchers have shown that some tumours use not one but two levels of protection against the immune system. Knocking out one level boosted the protective effects of the second and vice versa. The research demonstrates that a two-pronged approach targeting both cell types simultaneously may offer a promising route for the development of new cancer immunotherapies.
News • Deadly brain cancer
Personalized cancer vaccine may increase long-term survival
An international Phase 3 study has found that a personalized glioblastoma vaccine may increase long-term survival in some patients.
News • "WAKE-UP"
Study provides new treatment option for stroke patients
In an international study, scientists of the University Medical Center Hamburg-Eppendorf (UKE) have discovered a new therapeutic option for a large group of stroke patients. The main results of the European WAKE-UP trial were presented at the European Stroke Organisation Conference (ESOC) in Gothenburg, Sweden. At the same time, the trial results were published in the New England Journal of…
Article • Assisting algorithms
Big data advances rare disease diagnosis and cancer therapy
Two major projects feeding on big data and based in Spain have recently come under the spotlight: Mendelian, a tool to expedite rare diseases diagnosis, and Harmony, an EU platform that aims to improve targeted therapy in haematological cancer. Rare diseases affect as many as 6% of the Spanish population. Although this percentage is high, these conditions are individually rare, which complicates…
News • Pivotal trial
Parkinson's disease: First patient treated with focused ultrasound
The first patient in a multicenter pivotal trial using focused ultrasound to address the major motor symptoms of Parkinson’s disease has been treated at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center in New York. This randomized, double-blind clinical trial is evaluating the safety and efficacy of using Insightec’s Exablate Neuro device in more than 100 patients…
News • Research support
Stem cell therapy for traumatic injury on the horizon
The University of Texas Health Science Center at Houston (UTHealth) has received funding through a public/private partnership for the first-ever clinical trial investigating a stem cell therapy for early treatment and prevention of complications after severe traumatic injury. The proposed Phase 2 trial is underwritten with $2 million from the Medical Technology Consortium (MTEC) and $1.5 million…
News • Matrix-forming proteins
Experimental targeted therapy might prevent heart failure
Scientists used an experimental targeted molecular therapy to block a matrix-forming protein in heart cells damaged by heart attack, reducing levels of scarred muscle tissue and saving mouse models from heart failure. Researchers at the Cincinnati Children’s Heart Institute report in the journal Circulation testing a manufactured peptide called pUR4 to block the fibronectin protein in human…
News • Immunotherapy
Promising vaccine suppresses peanut allergies in mice
A vaccine may successfully turn off peanut allergy in mice, a new study shows. Just three monthly doses of a nasal vaccine protected the mice from allergic reactions upon exposure to peanut, according to research from the Mary H. Weiser Food Allergy Center at the University of Michigan. The study, funded by grants from Food Allergy Research and Education (FARE) and the Department of Defense, was…
News • Otolaryngology
Treating head and neck cancer — the patient's perspective
Jan Walker, a retired administrative assistant to the superintendent of Boaz City Schools, was getting ready for her regular doctor visit and noticed a lump on her neck. Her primary care physician examined it and determined it was a simple swollen lymph node. Two months later, she began to lose feeling on the right side of her throat and noticed the lump had increased in size. After seeing other…
News • Breast cancer
Double mastectomy slashes risk - but not for all women
Healthy women who carry a breast cancer-causing mutation in the BRCA1 gene, not only reduce their risk of developing the disease but also their chances of dying from it if they have both breasts removed, according to new research presented at the 11th European Breast Cancer Conference. However, the study also found that for women with a mutation in the BRCA2 gene, there was no difference in their…
News • Power of the heart
Gene therapy can make the heart stop atrial fibrillation itself
The heart is capable of terminating arrhythmias itself after local gene therapy, potentially avoiding the need for patients to undergo painful electric shocks, according to a proof-of-concept study presented today at EHRA 2018, a European Society of Cardiology congress. Atrial fibrillation is the most common heart rhythm disorder (arrhythmia). Treatment aims to restore the heart’s normal rhythm…
Article • Predictive biomarkers
Immunotherapy follow-up with MRI: the search is on
Immunotherapy is taking center stage in imaging, but patient follow-up with CT is no cookie and may fall short in the peripheral limbs, brain and bone marrow. MRI offers specific benefits in these situations, and, combined with PET, it may bring even more results. Research must be carried out on quantitative techniques and tracers developed to fully exploit that potential, Prof. Dow-Mu Koh…
Article • New therapies, new questions
To understand an image is to understand the treatment
Conventional chemotherapy in oncology is increasingly yielding to new procedures such as targeted therapy and immunotherapy. This results in changes for radiologists because new procedures require familiarisation with certain imaging to ensure that the treatment process is interpreted correctly.
News • HER2 breast cancer
‘Soft’ chemotherapy plus targeted treatment spell new hope for elderly patients
Avoidance of side-effects of chemotherapy is particularly important in the elderly, but finding the balance between reduced toxicity and maximum effectiveness is not always easy. A trial carried out by the European Organisation for Research and Treatment of Cancer, published in The Lancet Oncology, shows that, in older patients with HER2 positive metastatic breast cancer (an aggressive breast…
Video • TCAR (Transcarotid artery revascularization)
Reversing blood flow reduces stroke risk during carotid artery procedure
Loyola Medicine is the first academic medical center in Illinois to use the TCAR system, which reduces stroke risk during carotid artery procedures by temporarily reversing blood flow. Carotid arteries on each side of the neck supply blood to the brain. In patients with carotid artery disease, a build-up of plaque can cause blockages. A common method to open the artery involves a balloon…
News • Interactive tool
Breast cancer: Improving patient knowledge of treatment options
Breast cancer patients face complex decisions about their treatment. “Knowledge is a key component of decision making, and yet it’s consistently low even among patients who have received treatment. We need better tools to make these decisions more informed,” says Sarah T. Hawley, Ph.D., MPH, professor of internal medicine at Michigan Medicine. Hawley and colleagues from the Cancer…
News • Fighting cancer
Light-triggered nanoparticles show promise against metastatic cancer
Tumor imaging technique has potential as anti-cancer weapon, mouse study shows.
News • Microbubbles
Bracco Imaging to innovate ultrasound for new personalized gene therapy
Bracco Imaging S.p.A., a global leader in diagnostic imaging, announced that it has initiated new experimental activities in its R&D Center in Geneva, Switzerland, to explore a new application for gas-filled microbubbles in the development of personalized gene therapy for treatment of chronic dysfunctional diseases related to lipid metabolism. Microbubbles have already revolutionized medical…
News • Antiviral design
CAR-T gene therapy could provide long-term HIV protection
Through gene therapy, researchers engineered blood-forming stem cells (hematopoietic stem/progenitor cells, or HSPCs) to carry chimeric antigen receptor (CAR) genes to make cells that can detect and destroy HIV-infected cells. These engineered cells not only destroyed the infected cells, they persisted for more than two years, suggesting the potential to create long-term immunity from the virus…
